“Chulalongkorn Hospital” Thai Red Cross Society, Faculty of Medicine Chulalongkorn University and the Vaccine Research Center Faculty of Medicine, Chulalongkorn University announces the test “covid vaccine” “ChulaCOV19“which is a type of vaccine”mRNA“Thai nationality by volunteers who pass the screening that are healthy in Phase 1 reveal that they can resist “Covid-19” Up to 4 species and there are many other outstanding points.
injection test progress “Covid vaccine” “ChulaCov19” (Chula-Koff-Nine-Teen) type of vaccinemRNAIn a phase 1 trial in healthy volunteers who passed the screening, it was found that the volunteers had good immunity. Highly stimulating antibodies to inhibit the original strain. and can inhibit cross-infection of all 4 strains, namely alpha, beta, gamma and delta by more than 80%.
“covid vaccine“ChulaCov19” also stimulates T-Cell immunity, which will help eliminate and control the infection in the cells of infected people. Accelerate the preparation of production And prepare to register for use in the next emergency
In other cases, the highlight of the vaccine.”ChulaCov19“There will be both
1. From the temperature resistance test of the vaccine, it was found that ChulaCov19 vaccine It can be refrigerated (2-8C) for up to 3 months and at room temperature (25C) for up to 2 weeks, which makes it easier to store than other mRNA vaccine brands. very much
2. The results of animal testing were very good. From experiments in a special type of rats designed to cause disease.Covid-19 It was found that when the rats were vaccinated ChulaCov19 After completing 2 injections, 3 weeks apart, the rats were given the covid-19 infection through the nose, which could prevent the rats from getting sick and stop the virus from entering the bloodstream. as well as reducing the number of infections in the nose and lungs by at least 10,000,000 times
When tested for toxicity, it was found to be safe. As for the unvaccinated mice, they will develop symptoms of COVID-19 within 3-5 days, and all of them are highly infected in the bloodstream, nose and lungs.
3. The mRNA vaccine can be produced quickly. No need to wait for culture like some vaccines. But mRNA vaccines can be used to design vaccines by knowing the strain of the virus. Synthetic in vitro. Up to 4 weeks, the vaccine can be tested in rats. This fast production This eliminates the need for large factories. In addition, when a mutant is present, vaccines can be synthesized faster as well.
Thank you information from Faculty of Medicine Chulalongkorn University www.md.chula.ac.th
.
